|
REEP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.41239999976273E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.23019999742624E-08 |
| Normal-vs-Stage2 |
4.184500E-04 |
| Normal-vs-Stage3 |
8.215200E-03 |
| Normal-vs-Stage4 |
1.412190E-01 |
| Stage1-vs-Stage2 |
4.672600E-01 |
| Stage1-vs-Stage3 |
5.663900E-02 |
| Stage1-vs-Stage4 |
1.919830E-01 |
| Stage2-vs-Stage3 |
4.578000E-01 |
| Stage2-vs-Stage4 |
5.492200E-01 |
| Stage3-vs-Stage4 |
9.660400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.50939999574862E-08 |
| Normal-vs-AfricanAmerican |
1.79866999999723E-05 |
| Normal-vs-Asian |
1.740200E-02 |
| Caucasian-vs-AfricanAmerican |
7.464200E-01 |
| Caucasian-vs-Asian |
8.776600E-01 |
| AfricanAmerican-vs-Asian |
9.700800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63458135915562E-12 |
| Normal-vs-Female |
8.686300E-02 |
| Male-vs-Female |
3.09870000003709E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.67570000000939E-05 |
| Normal-vs-Extreme_Weight |
2.06523687040772E-12 |
| Normal-vs-Obese |
4.445000E-04 |
| Normal-vs-Extreme_Obese |
6.44349999999738E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.928440E-01 |
| Normal_Weight-vs-Obese |
3.090000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.496800E-01 |
| Extreme_Weight-vs-Obese |
3.163800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.807800E-01 |
| Obese-vs-Extreme_Obese |
1.452160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.104000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.63789999996222E-06 |
| Normal-vs-Age(61-80Yrs) |
1.69900005175805E-09 |
| Normal-vs-Age(81-100Yrs) |
4.57819999999387E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.950800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.400040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.451800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.481800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.909800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.811200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62980740014973E-12 |
| Normal-VS-Type2 PRCC |
2.14979999999532E-05 |
| Normal-VS-KIRP CIMP |
3.112200E-01 |
| Normal-VS-Unclassified PRCC |
2.904700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.755890E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.321300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.884000E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.056200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.155200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.620000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.92810000082733E-08 |
| Normal-vs-N1 |
7.927800E-02 |
| Normal-vs-N2 |
9.784000E-01 |
| N0-vs-N1 |
5.648400E-02 |
| N0-vs-N2 |
2.953800E-01 |
| N1-vs-N2 |
4.406800E-01 |
|
|
